INTESTINAL TRANSIT TIME INCREASED

INTESTINAL TRANSIT TIME INCREASED was reported 32 times

These drug classes are most commonly taken by patients reporting INTESTINAL TRANSIT TIME INCREASED:

# Drug Count
0 Nonsteroidal Anti-inflammatory Drug [EPC] 4
1 Corticosteroid [EPC] 3
2 Proton Pump Inhibitor [EPC] 3
3 Tumor Necrosis Factor Blocker [EPC] 3
4 BCL-2 Inhibitor [EPC] 2
5 CD20-directed Cytolytic Antibody [EPC] 2
6 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2
7 GLP-1 Receptor Agonist [EPC] 2
8 Integrin Receptor Antagonist [EPC] 2
9 Interleukin-17A Antagonist [EPC] 2
10 Janus Kinase Inhibitor [EPC] 2
11 Lipid-based Polyene Antifungal [EPC] 2
12 Opioid Agonist [EPC] 2
13 Polyene Antifungal [EPC] 2
14 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 2
15 Sulfonamide Antimicrobial [EPC] 2
16 Aldosterone Antagonist [EPC] 1
17 Alkylating Drug [EPC] 1
18 Aminosalicylate [EPC] 1
19 Anti-epileptic Agent [EPC] 1
20 Atypical Antipsychotic [EPC] 1
21 Azole Antifungal [EPC] 1
22 Benzodiazepine [EPC] 1
23 CTLA-4-directed Blocking Antibody [EPC] 1
24 Central Nervous System Stimulant [EPC] 1
25 Folate Analog Metabolic Inhibitor [EPC] 1
26 GLP-2 Analog [EPC] 1
27 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 1
28 Guanylate Cyclase-C Agonist [EPC] 1
29 Histamine-2 Receptor Antagonist [EPC] 1
30 Human Immunoglobulin G [EPC] 1
31 Loop Diuretic [EPC] 1
32 Microtubule Inhibitor [EPC] 1
33 Osmotic Laxative [EPC] 1
34 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1
35 Platinum-based Drug [EPC] 1
36 Potassium Salt [EPC] 1
37 Programmed Death Ligand-1 Blocker [EPC] 1
38 Purine Antimetabolite [EPC] 1
39 Rifamycin Antibacterial [EPC] 1
40 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
41 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
42 mu-Opioid Receptor Agonist [EPC] 1